A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell linesDina Schneider, Rimas J. Orentas|Journal for ImmunoTherapy of Cancer|2017Cited by 261
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M. Knight, Nirav N. Shah, Igli Arapi et al.|Communications Medicine|2022Cited by 16